Letters NICE on VTE diseases

Authors’ reply to Makowska-Webb, Byatt, D’Costa, and Hart

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e5098 (Published 31 July 2012) Cite this as: BMJ 2012;345:e5098
  1. G Stansby, professor of vascular surgery1,
  2. R Agarwal, senior lecturer/honorary consultant medical oncologist2,
  3. B Hunt, professor of thrombosis and haemostasis3,
  4. S Ballard, patient/carer representative on CG1444
  1. 1Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK
  2. 2Imperial College, London, UK
  3. 3King’s College, London, UK
  4. 4Reading, UK
  1. gerard.stansby{at}nuth.nhs.uk

Your correspondents raise several issues about CG144, most of which are dealt with in the full guideline,1 2 including how the evidence for each outcome was considered and graded. We would encourage them to read it. National Institute for Health and Clinical Excellence (NICE) guidance consistently uses “offer” and “consider,” words that acknowledge patient choice in treatment decisions and are standard vocabulary in all …

View Full Text

Log in

Log in through your institution


* For online subscription